Vol 15, No 3 (June 30, 2026): Chinese Clinical Oncology

Network pharmacology of Sijunzi decoction in pancreatic cancer

Efficacy and safety of TAS-102 followed by regorafenib or reverse sequence in later-line treatment of metastatic colorectal cancer: a systematic review and meta-analysis

Optimizing media composition for patient-derived organoids in ovarian cancer: a narrative review

Differentiating glioma recurrence from radiation necrosis: a narrative review of positron emission tomography and magnetic resonance imaging and their diagnostic accuracies

Biliary neuroendocrine tumors: a narrative review of current diagnostics and management strategies

Epidemiology, diagnosis, and treatment of primary pulmonary mucosa-associated lymphoid tissue lymphoma

Drug-induced liver injury and acute pancreatitis during trastuzumab therapy in a BRCA1-mutated, HER2-positive breast cancer patient: a case report

Combination therapy in sarcomas and the challenges of heterogeneity

Back to the future: “7+3” joins the venetoclax plus intensive chemotherapy movement

Clonal hematopoiesis in breast cancer: moving beyond prevalence toward clinical relevance

Age, endocrine therapy persistence, and recurrence risk in hormone receptor-positive early breast cancer: clarifying a long-standing clinical question

Can recurrence-free survival replace overall survival for resectable esophageal cancer?

Adjuvant CDK4/6 inhibitors and novel therapies in early breast cancer: lessons from monarchE overall survival data

Venetoclax with intensive chemotherapy in acute myeloid leukemia

Toxicity management in thoracic chemoradioimmunotherapy: pirfenidone for low grade pneumonitis and lung fibrosis